| Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy P Figueiredo, A Lepland, P Scodeller, F Fontana, G Torrieri, M Tiboni, ... Acta biomaterialia 133, 231-243, 2021 | 94 | 2021 |
| Targeting pro-tumoral macrophages in early primary and metastatic breast tumors with CD206-binding mUNO peptide A Lepland, EK Asciutto, A Malfanti, L Simón-Gracia, V Sidorenko, ... Molecular Pharmaceutics, 2020 | 33 | 2020 |
| Phage-display-derived peptide binds to human CD206 and modeling reveals a new binding site on the receptor EK Asciutto, S Kopanchuk, A Lepland, L Simón-Gracia, C Aleman, ... The Journal of Physical Chemistry B 123 (9), 1973-1982, 2019 | 22 | 2019 |
| Decreased Virulence of Ross River Virus Harboring a Mutation in the First Cleavage Site of Nonstructural Polyprotein Is Caused by a Novel Mechanism Leading to Increased … X Liu, M Mutso, A Utt, A Lepland, LJ Herrero, A Taylor, J Bettadapura, ... mBio 9 (4), e00044-18, 2018 | 18 | 2018 |
| Depletion of Mannose Receptor–Positive Tumor-associated Macrophages via a Peptide-targeted Star-shaped Polyglutamate Inhibits Breast Cancer Progression in Mice A Lepland, A Malfanti, U Haljasorg, EK Asciutto, M Pickholz, M Bringas, ... Cancer Research Communications 2 (6), 533-551, 2022 | 7 | 2022 |
| P01. 07 Depletion of CD206high tumour-associated macrophages using a nanoconjugate limits tumour burden & dissemination in metastatic triple negative breast cancer in mice A Lepland, A Malfanti, U Haljasorg, S Dordevic, L Salumäe, P Peterson, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 1), 2021 | | 2021 |
